Mirum Pharmaceuticals, Inc. ( MIRM) - Stock Earnings
MIRM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
MIRM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.7 million USD | 148.9 million USD |
| 2026Q1 | -790.2 million USD | 159.9 million USD |
| 2026Q2 | -67.2 million USD | 176.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MIRM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -163.4 million USD | 186.4 million USD |
| 2024 | -87.9 million USD | 336.9 million USD |
| 2025 | -23.4 million USD | 521.3 million USD |
| 2026 Est. | — | — |
MIRM
Price: $82.39
52 week price:
Earnings Per Share: -13.81 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 266732
Market Capitalization: 4.8 billion